Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab + methotrexate: the BeST induction therapy for early RA?
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :
Access to resources
Recommend
Preference for methotrexate in early RA increases
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :
Adalimumab more cost effective than infliximab in early RA
Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. :
Adalimumab more cost effective than infliximab in early RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :